Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrdokht Sadrkhanloo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Heliyon|March 10, 2022
Key plasma microRNAs variations in patients with <i>Plasmodium vivax</i> malaria in IranRamtin Hadighi, Aliehsan Heidari, Parviz Fallah, et al.
Pharmacological Reports : PR|March 15, 2023
Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenineMoein Ala, Mohammad Reza Fallahpour Khoshdel, Razieh Mohammad Jafari, et al.
European Journal of Pharmacology|September 2, 2022
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy responseMehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology|April 11, 2022
Non-coding RNAs and macrophage interaction in tumor progressionMaliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Life Sciences|April 23, 2022
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targetingMehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pathology, Research and Practice|March 27, 2022
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translationMojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2022
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodelingMaliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Pharmacological Research|June 18, 2022
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy responseMehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functionsMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology, Research and Practice|November 3, 2023
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesisMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Heliyon|March 10, 2022
Key plasma microRNAs variations in patients with <i>Plasmodium vivax</i> malaria in IranRamtin Hadighi, Aliehsan Heidari, Parviz Fallah, et al.
Pharmacological Reports : PR|March 15, 2023
Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenineMoein Ala, Mohammad Reza Fallahpour Khoshdel, Razieh Mohammad Jafari, et al.
European Journal of Pharmacology|September 2, 2022
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy responseMehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology|April 11, 2022
Non-coding RNAs and macrophage interaction in tumor progressionMaliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Life Sciences|April 23, 2022
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targetingMehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pathology, Research and Practice|March 27, 2022
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translationMojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2022
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodelingMaliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Pharmacological Research|June 18, 2022
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy responseMehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functionsMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology, Research and Practice|November 3, 2023
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesisMehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pageof 1